Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents - Wikidata - awgldk - TriplyDB

Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents

Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents

http://www.wikidata.org/entity/Q34453709

about

Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans Kappa Opioids, Salvinorin A and Major Depressive Disorder Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety.Novel 3-substituted rimonabant analogues lack Δ(9) -tetrahydrocannabinol-like abuse-related behavioural effects in mice.Elucidating cannabinoid biology in zebrafish (Danio rerio).Clerodane diterpenes: sources, structures, and biological activities.Tolerance to the Diuretic Effects of Cannabinoids and Cross-Tolerance to a κ-Opioid Agonist in THC-Treated Mice.Gut feelings about the endocannabinoid system.Salvinorin A reduces mechanical allodynia and spinal neuronal hyperexcitability induced by peripheral formalin injection.Acute and post-acute behavioral and psychological effects of salvinorin A in humans.Analysis of Salvinorin A in urine using microextraction in packed syringe and GC-MS/MS.Screening of Hallucinogenic Compounds and Genomic Characterisation of 40 Anatolian Salvia Species.Salvinorin A reduces neuropathic nociception in the insular cortex of the rat.

P2860

Q26776241-91BD19B4-FC40-4901-9239-93DFAC71F133 Q27300685-488E7E85-5683-4ECC-AFE8-28FAB07481C1 Q28075656-F2DADAE4-D14B-4849-8885-AE982DC4A690 Q30467220-E8C884ED-E12A-404E-B9F7-7A2F4F283893 Q34325119-23EE85F8-B5AD-4F79-BD3C-7541B0D5997E Q34401390-7BB37AA3-A1D6-42F7-924A-16E20A6709F7 Q34766609-CD9B7CF6-EFE1-4CAD-8365-AB2926F68A5A Q35906830-97F4EB2E-F239-47CE-9707-A904067D0924 Q36783972-4DF36412-1956-45D9-899D-B874FC221FC4 Q37090161-7A9AD603-DE68-4E99-B3F5-61F5DB13AD6E Q38902043-BC656B08-D808-44B1-9E71-BAB876B02C98 Q39732447-8C807074-774F-4545-B5B9-4B17184C9220 Q39761953-DE685D36-66D5-4535-82D6-569A367C31D4 Q42411070-4DA22D44-6ED1-48C0-B3A1-00A7D189F148 Q43842140-6CF6A556-0845-42F1-BF43-1E587E74C0C7 Q46178251-5B8BBDFD-D035-400E-91D0-AB4393186B1B Q46333990-D80108BD-98B4-40CF-8120-891ED9A7161E Q49629222-4F96011B-EEC4-4E5A-B895-1DC5BD8487A9

P2860

Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents

http://www.wikidata.org/entity/Q34453709

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Kappa opioid mediation of cann ...... ogen, salvinorin A, in rodents

@ast

Kappa opioid mediation of cann ...... ogen, salvinorin A, in rodents

@en

Kappa opioid mediation of cann ...... ogen, salvinorin A, in rodents

@nl

type

label

Kappa opioid mediation of cann ...... ogen, salvinorin A, in rodents

@ast

Kappa opioid mediation of cann ...... ogen, salvinorin A, in rodents

@en

Kappa opioid mediation of cann ...... ogen, salvinorin A, in rodents

@nl

prefLabel

Kappa opioid mediation of cann ...... ogen, salvinorin A, in rodents

@ast

Kappa opioid mediation of cann ...... ogen, salvinorin A, in rodents

@en

Kappa opioid mediation of cann ...... ogen, salvinorin A, in rodents

@nl

P1433

Q34453709-6B9D6EF7-8EF8-426A-B962-2FDAF02FB010

P1476

Q34453709-3D77021D-D395-42AC-82CE-AC9DB7B534C8

P2093

Q34453709-2BE89E07-81B0-40E3-8FAF-E3D359CC3BB5

Q34453709-35397F2B-B6BF-402E-BC73-051B8E21B042

Q34453709-451AF0ED-E4BD-429E-B16A-5A69D4F7BEB8

Q34453709-457212E7-82CD-49AF-B352-A01133CA8417

Q34453709-50A6BDB0-EA0F-41FB-8CCC-467D53F370D1

Q34453709-932C6762-0072-410B-B500-C0A51447E292

Q34453709-9E2A269D-703D-485D-A505-16C6687D887F

Q34453709-A0B3948E-BC2E-40BE-875A-17FF6E35F92A

Q34453709-D43AD23A-F120-4452-A113-3A9835B89AA1

Q34453709-E2BE9D9D-49DF-44EB-8601-D25AF2D196CF

P2860

Q34453709-100DD04F-5D06-4301-97AC-B371B58B2523

Q34453709-1D5CEE6B-17B2-4DB3-B249-97FB7F1D58B8

Q34453709-3B355B5F-5C13-499E-9B95-B64B2C138D34

Q34453709-41E24E39-019F-475E-86D8-4E7EDE29D4DF

Q34453709-45EA6576-05D4-4219-83F7-E47ECB3F3311

Q34453709-5150FDFF-9999-4119-9497-B237F31017A3

Q34453709-51A7898E-5D60-4990-9857-FAF8CDB9F09E

Q34453709-594A4AE3-2036-49C2-8267-A6107C2FE4B0

Q34453709-62F9E30B-DA0B-4BC0-86AD-31DB8F1C4EDB

Q34453709-6876A360-2B71-4704-8A6C-0F4F1D313820

P2888

Q34453709-2B0A9A7D-BFD3-4E79-9D4E-3C015C58082E

P304

Q34453709-F1FF425E-73CC-460D-99A5-6C86E34A1A2C

P31

Q34453709-181D8DEF-5270-4893-AEA4-8B4EF6CEE79E

P356

Q34453709-77160E80-F038-4BAF-92FB-008C243CA4FE

P433

Q34453709-833B3408-7958-4915-A32A-79EDAFA3F555

P478

Q34453709-9270A422-FB6D-4BFC-BD2A-5FBC9A180DE1

P50

Q34453709-E100AA70-024F-47CE-A150-10FAF7CDEB20

Q34453709-EA7736B4-936F-4491-A8EC-C7D31D4B7F53

P577

Q34453709-F524A6D0-A9E9-4D0C-A064-16385504E01C

P5875

Q34453709-3F64F8B8-2A6B-446C-BFDB-A21AD01729F2

P6179

Q34453709-36390FE3-E799-4D58-9E31-EDB41F7BE97B

P698

Q34453709-D5226874-70B3-41CC-9E71-62511915DDB2

P921

Q34453709-14e019c1-3520-489e-a1a3-744e3f87bde0

Q34453709-F757742B-85F2-4BD9-B90B-C9C5A5324D3C

P932

Q34453709-1B15E003-2755-47C3-8480-104595F7DE26

P356

S00213-010-1827-6

P1433

Psychopharmacology

P1476

Kappa opioid mediation of cann ...... ogen, salvinorin A, in rodents

@en

P2093

Anne F Gilliam

http://www.w3.org/2001/XMLSchema#string

Brian P Gilmour

http://www.w3.org/2001/XMLSchema#string

Charles E Twine

http://www.w3.org/2001/XMLSchema#string

D Matthew Walentiny

http://www.w3.org/2001/XMLSchema#string

F Ivy Carroll

http://www.w3.org/2001/XMLSchema#string

Herbert H Seltzman

http://www.w3.org/2001/XMLSchema#string

Hernán A Navarro

http://www.w3.org/2001/XMLSchema#string

Jonathan A Warner

http://www.w3.org/2001/XMLSchema#string

Lindsey S King

http://www.w3.org/2001/XMLSchema#string

Robert E Vann

http://www.w3.org/2001/XMLSchema#string

P2860

Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist

Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporter

Activation of G-proteins in brain by endogenous and exogenous cannabinoids

Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations

Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling and Játiva-M.)

Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats

Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement.

Cannabis: discrimination of "internal bliss"?

P2888

s00213-010-1827-6

P304

275-284

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00213-010-1827-6

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

210

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42768858

http://www.w3.org/2001/XMLSchema#string

P6179

1010028562

http://www.w3.org/2001/XMLSchema#string

P698

20354680

http://www.w3.org/2001/XMLSchema#string

P921

P932

3013230

http://www.w3.org/2001/XMLSchema#string